Target intelligence / Profile preview

Pathogenic antigens and toxins

Molecular classification
Other
01

Overview

Pathogenic antigens and toxins represent a broad functional category of molecules produced by infectious agents, such as bacteria, viruses, and fungi, that are central to the development of disease. Pathogenic antigens are molecular structures, often proteins or polysaccharides, that are recognized by the host's immune system and serve as the primary targets for vaccine development and diagnostic identification (Source: NIH). Toxins are specialized virulence factors, including exotoxins like botulinum or endotoxins like lipopolysaccharide, that directly damage host tissues by disrupting cellular membranes or interfering with essential biological processes (Source: StatPearls). In clinical pharmacology, specific members of this class are targeted by neutralizing monoclonal antibodies and antitoxins to mitigate the effects of severe infections. For example, bezlotoxumab is used to neutralize Clostridioides difficile toxin B, while raxibacumab targets the protective antigen of Bacillus anthracis (Source: FDA). Because this term encompasses thousands of distinct molecular entities across diverse species, it is considered a general classification rather than a single, well-defined therapeutic target.

Other names
Virulence factorsMicrobial antigensBacterial toxinsViral antigensExotoxinsEndotoxins
02

Mechanism of action

Neutralization of pathogenic molecules to prevent host cell binding, entry, or enzymatic activity.

03

Biological functions

Immune responseCell deathPathogenesisHost cell disruption
04

Disease associations

Infection
05

Safety considerations

Infusion-related reactionsHypersensitivityPotential for immune complex formationAntibody-dependent enhancement
06

Interacting drugs

Bezlotoxumab

8 more in the full profile.

07

Biomarkers

Serum toxin levelsAntigenemiaPathogen-specific antibody titers

Beyond the preview

Go deeper on Pathogenic antigens and toxins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic antigens and toxins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call